Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 174 | 333 | 153 | 3,480 | 685 |
| Gross Profit | 174 | 333 | 153 | 3,480 | 685 |
| Operating Expenses | 23,431 | 20,673 | 20,977 | 16,920 | 17,324 |
| Operating Income | -23,257 | -20,340 | -20,824 | -13,440 | -16,639 |
| Other Income | 207 | 192 | 145 | 67 | 101 |
| Pre-tax Income | -23,050 | -20,148 | -20,679 | -13,373 | -16,538 |
| Income Tax | N/A | N/A | -227 | N/A | N/A |
| Net Income Continuous | -23,050 | -20,148 | -20,452 | -13,373 | -16,538 |
| Net Income | $-23,050 | $-20,148 | $-20,452 | $-13,373 | $-16,538 |
| EPS Basic Total Ops | -0.49 | -0.43 | -0.45 | -0.34 | -0.42 |
| EPS Basic Continuous Ops | -0.49 | -0.44 | -0.45 | -0.34 | -0.42 |
| EPS Diluted Total Ops | -0.49 | -0.43 | -0.45 | -0.34 | -0.42 |
| EPS Diluted Continuous Ops | -0.49 | -0.44 | -0.45 | -0.34 | -0.42 |
| EBITDA(a) | $-21,674 | $-15,865 | $-23,306 | $-12,801 | $-15,912 |